Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference
SHANGHAI,Nov. 8,2024-- Mabwell (688062.SH),an innovative biopharmaceutical company with entire industry chain,showcased the "Preclinical Development of 7MW4811,an Mtoxin™ (MF6)-based Antibody-dr